#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmogenic right ventricular dysplasia Precursor T-lymphoblastic lymphoma/leukaemia recurrent Immunoglobulin G4 related disease Ureteric cancer Immune thrombocytopenia Bronchiolitis Metastases to central nervous system Small intestine leiomyosarcoma Pelizaeus-Merzbacher disease Laryngeal squamous cell carcinoma Loeys-Dietz syndrome ROHHAD syndrome Diffuse large B-cell lymphoma Gastrointestinal neuroendocrine tumour Frostbite More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Basic Information Uterine leiomyosarcoma Idiopathic pulmonary fibrosis – Trials in Disease Indolent systemic mastocytosis – Trials in Disease Antithrombin III deficiency Loeys-Dietz syndrome – Treatment Atypical haemolytic uraemic syndrome Leukoencephalopathy – Treatment Optic glioma – Life with Disease Shprintzen-Goldberg syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Potassium Chloride Gebasaxturev Cldn6 Rna-Lpx Istaroxime Metamizole Pancreas Powder GSK5460025A Ketamine Hydrochloride Terlipressin Acetate Sebetralstat Glenzocimab Tyra-300-B01 Diacerein Levetiracetam Xanomeline Tartrate Sodium Phenylbutyrate GSKVX000000017986 Pentixafor Gallium Ga-68 Sitagliptin L-Histidine Hydrochloride More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma Friedreich's ataxia Acute myeloid leukaemia Prostatitis Escherichia coli Sepsis Onychomycosis Transitional cell carcinoma Low cardiac output syndrome Herpes simplex Tumour thrombosis Menopausal symptoms Hernia repair Herpes simplex meningitis Ewing's sarcoma recurrent Renal impairment More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Gout

  • Study of Dapansutrile and Paracetamol for Patients with Acute Gout Flare

    Recruiting

    4 1 1
    Investigated Drugs:
    • Dapansutrile
    • Paracetamol
    France The Netherlands Spain

  • Study on Stopping Allopurinol or Febuxostat in Gout Patients in Remission

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gout
    Investigated Drugs:
    • Febuxostat
    • Allopurinol
    France

  • Study on Gout: Comparing Immediate vs. Delayed Use of Febuxostat for Patients with Acute Gout Attacks

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Gout
    Investigated Drugs:
    • Febuxostat
    France

  • Study on Treating Acute Gout Attacks with Prednisolone and Colchicine for Primary Care Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    • Prednisolone
    Germany

  • Study on Gout Treatment: Comparing Allopurinol, Benzbromarone, and Febuxostat in Patients with Gout in Remission

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gout
    • Gouty arthritis
    Investigated Drugs:
    • Febuxostat Hemihydrate
    • Allopurinol
    The Netherlands

  • Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Autumn Crocus Fresh Flower Fluid Extract (1:15-25), Extraction Solvent Ethanol 96% (V/V)
    • Tigulixostat
    • Naproxen
    Belgium Bulgaria Czechia France Germany Italy +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!